HalTutelle.i
Curation
Hal
Racine
Curation
Checkpoint
Hal
Racine
Hal
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Hal)

Index « HalTutelle.i » - entrée « CHRU Lille »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
CHRU Brest < CHRU Lille < CHRU Montpellier  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000002 (2015) Alice Courties [France] ; Gilles Grateau [France] ; Peggy Philippe ; René-Marc Flipo [France] ; Leonardo Astudillo [France] ; Bérengère Aubry-Rozier ; Isabelle Fabreguet ; Wafki Fahd ; Olivier Fain [France] ; Pascal Guggenbuhl [France] ; Eric Hachulla [France] ; Thomas Papo [France] ; Christophe Richez [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Francis Berenbaum [France] ; Jérémie Sellam [France]AA amyloidosis treated with tocilizumab: case series and updated literature review
000009 (2017) Arsene Mekinian [France] ; Guillaume Dervin [France] ; Nathanael Lapidus [France] ; Jean-Emmanuel Kahn [France] ; Louis Terriou [France] ; Eric Liozon [France] ; Eric Grignano [France] ; Jean-Charles Piette [France] ; Odile Beyne Rauzy ; Vincent Grobost [France] ; Pascal Godmer [France] ; Jerome Gillard [France] ; Julien Rossignol [France] ; David Launay [France] ; Achille Aouba [France] ; Thierry Cardon [France] ; Laurence Bouillet [France] ; Jonathan Broner [France] ; Julien Vinit [France] ; Lionel Ades [France] ; Fabrice Carrat [France] ; Clementine Salvado [France] ; Eric Toussirot [France] ; Mathilde Versini [France] ; Nathalie Costedoat-Chalumeau [France] ; Jean Baptiste Fraison [France] ; Philippe Guilpain [France] ; Pierre Fenaux [France] ; Olivier Fain [France]Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
000015 (2019) Jacques Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000017 (2017-11-03) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries
000030 (2017-11-03) Alain Saraux [France] ; René-Marc Flipo [France] ; Bernard Combe [France] ; Jacques Tebib [France] ; Christelle Baffie [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Factors influencing the prescription of Tocilizumab alone or in combination with Dmards in rheumatoid arthritis patients in a real life setting. Pooled analysis of 2 observational studies.
000031 (2017-01-10) René-Marc Flipo [France] ; Jean-Francis Maillefert [France] ; Pascal Chazerain [France] ; Isabelle Idier [France] ; Mathieu Coudert [France] ; Jacques Tebib [France]Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study
000033 (2016-06) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Émilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sebastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France] ; French Society Of Dermatology And Club Rheumatisms And InflammationHidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
000038 (2018-11-15) Frits Van Rhee ; Peter Voorhees ; Angela Dispenzieri ; Alexander Foss ; Gordan Srkalovic ; Makoto Ide ; Nikhil Munshi ; Stephen Schey ; Matthew Streetly ; Sheila Pierson ; Helen Partridge ; Sudipto Mukherjee ; Dustin Shilling ; Katie Stone ; Amy Greenway ; Jason Ruth ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan ; Raj Jayanthan ; Elaine Jaffe ; Heather Leitch ; Naveen Pemmaraju ; Amy Chadburn ; Megan Lim ; Kojo Elenitoba-Johnson ; Vera Krymskaya ; Aaron Goodman ; Christian Hoffmann ; Pier Luigi Zinzani ; Simone Ferrero ; Louis Terriou [France] ; Yasuharu Sato ; David Simpson ; Raymond Wong ; Jean-François Rossi [France] ; Sunita Nasta ; Kazuyuki Yoshizaki ; Razelle Kurzrock ; Thomas Uldrick ; Corey Casper ; Eric Oksenhendler [France] ; David FajgenbaumInternational, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
000052 (2017-07-14) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE
000073 (2010-06) Thao Pham ; Pascal Claudepierre [France] ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel [France] ; Laure Gossec [France] ; Jacques-Eric Gottenberg ; Philippe Goupille [France] ; Severine Guillaume [France] ; Eric Hachulla [France] ; Charles Masson ; Jacques Morel [France] ; Xavier Puechal ; Alain Saraux ; Thierry Schaeverbeke [France] ; Daniel Wendling ; Eric Bruckert [France] ; Stanislas Pol [France] ; Xavier Mariette [France] ; Jean SibiliaTocilizumab therapy and safety management

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Hal/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/HalTutelle.i -k "CHRU Lille" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/HalTutelle.i  \
                -Sk "CHRU Lille" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Hal
   |étape=   Curation
   |type=    indexItem
   |index=    HalTutelle.i
   |clé=    CHRU Lille
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021